Lycium barbarum Polysaccharide Inhibited Hypoxia-Inducible Factor 1 in COPD Patients

Abstract

Li-Jun Chen,1,2 Wang Xu,1 Ya-Ping Li,3 Li-Ting Ma,1 Hui-Fang Zhang,1 Xiao-Bo Huang,1 Geng-Geng Yu,1 Xiu-Qin Ma,1 Chao Chen,1 Yan-Hong Liu,1 Jie Wu,4 Li-Jun Wang,4 Yuan Xu4 1Department of Respiratory and Critical Medicine, The First People’s Hospital of Yinchuan City, Yinchuan, Ningxia, People’s Republic of China; 2Department of Respiratory and Critical Medicine, The Second Affiliated Hospital of Ningxia Medical University, Yinchuan, Ningxia, People’s Republic of China; 3Department of Respiratory Medicine, Weihai Municipal Hospital of Shandong Province, Weihai, Shandong, People’s Republic of China; 4Department of Clinical Institute, Ningxia Medical University, Yinchuan, Ningxia, People’s Republic of ChinaCorrespondence: Li-Jun ChenDepartment of Respiratory and Critical Medicine, The Second Affiliated Hospital of Ningxia Medical University, No. 2, Liqun West Street, Xingqing District, Yinchuan, Ningxia 750001, People’s Republic of ChinaTel [phone]Fax [phone]Email [email protected]: Chronic obstructive pulmonary disease (COPD) is a chronic airway inflammatory disease characterized by irreversible airflow obstruction. Pathogenic mechanisms underlying COPD remain largely unknown.Objective: The current study was designed to explore serum concentration of hypoxia-inducible factor 1α (HIF-1α) in stable COPD patients and the potential effect of Lycium barbarum polysaccharides (LBP) on HIF-1α protein expression.Methods: Serum HIF-1α was quantified by ELISA in 102 stable COPD patients before and after 2-week orally taken LBP (100 mL/time, twice daily, 5– 15 mg/mL). Correlation of serum LBP and lung function (FEV1%) or blood gas (PO2 and PCO2) was also analyzed. As a control, 105 healthy subjects were also enrolled into this study.Results: Serum concentration of HIF-1α was significantly higher in the stable COPD patients (37.34 ± 7.20 pg/mL) than that in the healthy subjects (29.55 ± 9.66 pg/mL, P< 0.001). Oral administration of LBP (5 mg/mL, 100 mL, twice daily for 2 weeks) not only relieved COPD symptoms but also significantly reduced serum HIF-1α concentration (36.94 ± 9.23 vs 30.49 ± 6.42 pg/mL, P< 0.05). In addition, level of serum HIF-1α concentration was significantly correlated with PCO2 (r = 0.283, P< 0.001), but negatively and significantly correlated with PO2 (r = − 0.490, P=0.005) or FEV1%(r = − 0.420, P=0.018).Conclusion: These findings suggested that activation of HIF-1 signaling pathway may be involved in the pathophysiology of COPD and that stabilization of serum HIF-1α concentration by LBP might benefit the stable COPD patients.Keywords: chronic obstructive pulmonary disease, COPD, hypoxia-induced factor 1, HIF-1, Lycium barbarum polysaccharides, LBP

Keywords

• chronic obstructive pulmonary disease (copd)
• hypoxia induced factor 1 (hif-1)
• lycium barbarum polysaccharides (lbp)